Medicare: Laboratory Fee Schedules Produced Large Beneficiary Savings but No Program Savings
HRD-88-32
Published: Dec 22, 1987. Publicly Released: Dec 22, 1987.
Skip to Highlights
Highlights
Pursuant to a legislative requirement, GAO reviewed the appropriateness and impact of Medicare's fee schedule payment system for clinical diagnostic laboratory services.
Recommendations
Matter for Congressional Consideration
Matter | Status | Comments |
---|---|---|
The Senate Committee on Finance, the House Committee on Ways and Means, and the House Committee on Energy and Commerce should take action to prevent adoption of a national laboratory fee schedule based on prevailing charges because using that methodology would increase Medicare costs. | The Omnibus Budget Reconciliation Act of 1989 repealed the requirement for a national fee schedule for clinical diagnostic laboratory services. | |
The Senate Committee on Finance, the House Committee on Ways and Means, and the House Committee on Energy and Commerce should take action to prevent adoption of a national laboratory fee schedule based on prevailing charges because using that methodology would increase Medicare costs. | The Omnibus Budget Reconciliation Act of 1989 repealed the requirement for a national fee schedule for clinical diagnostic laboratory services. | |
The Senate Committee on Finance, the House Committee on Ways and Means, and the House Committee on Energy and Commerce should take action to prevent adoption of a national laboratory fee schedule based on prevailing charges because using that methodology would increase Medicare costs. | The Omnibus Budget Reconciliation Act of 1989 repealed the requirement for a national fee schedule for clinical diagnostic laboratory services. |
Full Report
Office of Public Affairs
Topics
Disease detection or diagnosisHealth care facilitiesHealth insurance cost controlLaboratoriesMedical feesMedicareStatistical methodsHospitalsBeneficiariesPhysicians